Cancer drug listing

Find detailed information for nearly 200 cancer drugs, including brand and generic names for each drug, what it is intended to treat, how it is administered, and possible side effects.

To find out if a Food and Drug Administration-approved drug is in short supply, visit the FDA website.

Showing results for:

Imetelstat

Drug name(s)

Rytelo Imetelstat

Approved for

  • Myelodysplastic Syndromes (MDS)

Inotuzumab Ozogamicin

Drug name(s)

Besponsa® Inotuzumab Ozogamicin

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)

Interferon alfa-2a

Drug name(s)

Roferon®-A Interferon alfa-2a

Approved for

  • Chronic Myeloid Leukemia (CML)
  • Hairy Cell Leukemia (HCL)
  • Other Blood Cancers

Interferon alfa-2b

Drug name(s)

Intron® A Interferon alfa-2b

Approved for

  • Leukemia
  • Hairy Cell Leukemia (HCL)
  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)
  • Follicular Lymphoma (FL) 
  • Polycythemia Vera

Isatuximab-irfc

Drug name(s)

Isatuximab-irfc Sarclisa® Sarclisa Escena™

Approved for

  • Myeloma

Ivosidenib

Drug name(s)

Tibsovo® Ivosidenib

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)

Ixazomib

Drug name(s)

NINLARO® Ixazomib

Approved for

  • Myeloma

Lenalidomide

Drug name(s)

Revlimid® Lenalidomide

Approved for

  • Leukemia
  • Chronic Lymphocytic Leukemia (CLL/SLL)
  • Lymphoma
  • Follicular Lymphoma (FL) 
  • Mantle Cell Lymphoma (MCL) 
  • Marginal Zone Lymphoma (MZL) 
  • Myeloma
  • Myelodysplastic Syndromes (MDS)

Leucovorin

Drug name(s)

Folinic acid Leucovorin Levoleucovorin Fusilev®

Approved for

  • Other Blood Cancers

Linvoseltamab-gcpt

Drug name(s)

Lynozyfic™ Linvoseltamab-gcpt

Approved for

  • Myeloma

Liposomal doxorubicin

Drug name(s)

Doxil® Liposomal doxorubicin

Approved for

  • Myeloma

Lisocabtagene maraleucel

Drug name(s)

Breyanzi® Lisocabtagene maraleucel

Approved for

  • Leukemia
  • Chronic Lymphocytic Leukemia (CLL/SLL)
  • Lymphoma
  • Follicular Lymphoma (FL) 
  • Mantle Cell Lymphoma (MCL) 

Lomustine

Drug name(s)

CeeNU® CCNU Lomustine

Approved for

  • Lymphoma
  • Hodgkin Lymphoma (HL)

Loncastuximab

Drug name(s)

Zynlonta™ Loncastuximab tesirine-lpyl

Approved for

  • Lymphoma
  • Diffuse Large B-cell Lymphoma (DLBCL) 
  • High-grade B-cell Lymphoma with double or triple hits (HBL)

Luspatercept-aamt

Drug name(s)

Reblozyl® Luspatercept-aamt

Approved for

  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)

Mechlorethamine

Drug name(s)

Mustargen® nitrogen mustard Mechlorethamine

Approved for

  • Chronic Lymphocytic Leukemia (CLL/SLL)
  • Chronic Myeloid Leukemia (CML)
  • Lymphoma
  • Hodgkin Lymphoma (HL)
  • Polycythemia Vera

Mechlorethamine gel

Drug name(s)

Valchlor® Mechlorethamine gel

Approved for

  • Lymphoma
  • Adult T-cell Leukemia/Lymphoma
  • Other Blood Cancers

Melphalan

Drug name(s)

Alkeran® Melphalan

Approved for

  • Myeloma

Melphalan hydrochloride

Drug name(s)

Evomela™ Melphalan hydrochloride

Approved for

  • Myeloma

Mercaptopurine

Drug name(s)

Purinethol® 6-MP Purixan® Mercaptopurine

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)

Methotrexate

Drug name(s)

Rheumatrex® Trexall® Methotrexate

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Non-Hodgkin Lymphoma (NHL)
  • Other Blood Cancers

Midostaurin

Drug name(s)

Rydapt® Midostaurin

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Other Blood Cancers

Mitomycin

Drug name(s)

Mutamycin® Mitomycin

Approved for

  • Other Blood Cancers

Mitoxantrone

Drug name(s)

Novantrone® Mitoxantrone

Approved for

  • Leukemia
  • Other Blood Cancers

Mogamulizumab

Drug name(s)

Poteligeo® Mogamulizumab

Approved for

  • Other Blood Cancers

Momelotinib

Drug name(s)

Momelotinib Ojjaara

Approved for

  • Essential Thrombocythemia
  • Primary Myelofibrosis
  • Polycythemia Vera

Mosunetuzumab-axgb

Drug name(s)

Mosunetuzumab-axgb Lunsumio® Lunsumio VELO™

Approved for

  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)
  • Follicular Lymphoma (FL) 

Nelarabine

Drug name(s)

Arranon® Nelarabine

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Lymphoma

Nilotinib

Drug name(s)

Tasigna® Danziten™ Cavhanza™ Nilotinib

Approved for

  • Leukemia
  • Chronic Myeloid Leukemia (CML)

Nivolumab

Drug name(s)

Opdivo® Nivolumab

Approved for

  • Lymphoma
  • Hodgkin Lymphoma (HL)

Obecabtagene autoleucel

Drug name(s)

Aucatzyl® Obecabtagene autoleucel

Approved for

  • Acute Lymphoblastic Leukemia (ALL)

Obinutuzumab

Drug name(s)

Gazyva® Obinutuzumab

Approved for

  • Chronic Lymphocytic Leukemia (CLL/SLL)
  • Lymphoma
  • Follicular Lymphoma (FL) 

Ofatumumab

Drug name(s)

Arzerra® Ofatumumab

Approved for

  • Leukemia
  • Chronic Lymphocytic Leukemia (CLL/SLL)

Olutasidenib

Drug name(s)

Olutasidenib Rezlidhia™

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)

Omacetaxine mepesuccinate

Drug name(s)

Synribo® Omacetaxine mepesuccinate

Approved for

  • Chronic Myeloid Leukemia (CML)

Omidubicel-onlv

Drug name(s)

Omidubicel-onlv Omisirge®

Approved for

  • Other Blood Cancers

Pacritinib

Drug name(s)

Vonjo™ Pacritinib

Approved for

  • Primary Myelofibrosis
  • Polycythemia Vera
  • Other Blood Cancers

Palifermin

Drug name(s)

Kepivance® Palifermin

Approved for

  • Other Blood Cancers

Pamidronate

Drug name(s)

Aredia® Pamidronate

Approved for

  • Myeloma
  • Other Blood Cancers

Panobinostat

Drug name(s)

Farydak® Panobinostat

Approved for

  • Myeloma

Can’t find what you’re looking for?
Contact a Blood Cancer United Information Specialist.

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.